Innovation in the world of inhalation pharmaceuticals

Thanks to the scalability of the MG2 technology, Hovione - world renowned CDMO - completes a path of innovation, moving from R&D to actual production.

This is the result of a longterm partnership between MG2 and Hovione, a leading multinational in the pharmaceutical sector with headquarters in the USA, China, Ireland and Portugal and internationally recognized research laboratories in Lisbon and New Jersey. And it is in the Portuguese headquarters - involved in a process of consolidation of experimental and production capacities - that MG2 has installed TEKNA, a new containment capsule filling machine for low doses.
 
Growth objectives. The aim of the new production line is the completion of products and services that Hovione can now offer to its customers: a market positioning acquired also thanks to the scalability of the MG2 machines, which enable the replication of laboratory experiences in the subsequent production phase. And this is the case of Hovione, which first followed an R&D path with the FlexaLAB laboratory capsule filler equipped with MultiNETT, and then continued in the production phase, with the inclusion of the new TEKNA capper for inhalation applications.
 
Advanced research, technology. MG2 has in fact developed a specific path of innovation and technological research focused on these applications, which require extreme dosing accuracy and stability of the filling process over time. The TEKNA capping unit, installed at the Hovione plant in Portugal, ensures a production capacity of 110,000 capsules per hour, and is suitable for the management of so-called “high potent” substances.
TEKNA, like FlexaLAB is also equipped with the MultiNETT system for the 100% net weight control in process. Furthermore, in the dosage group, TEKNA integrates the no capsule no dosage solution, which inhibits dosage in the absence of the empty capsule.
MG2 is in fact able to offer a whole range of capsule fillers: from research and development to production, from the technical to the clinical up to the production batch. Different machines able to replicate identical operating parameters on different scales, thus satisfying the various needs of the market.